Picture of Eli Lilly and logo

LLY — Eli Lilly and News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Lilly signs oncology research deal with Stipple Bio worth up to $5.9 billion

Lilly signs oncology research deal with Stipple Bio worth up to $5.9 billion

- Eli Lilly LLY.N has signed an oncology research collaboration and licensing agreement worth up to $5.9 billion with private biotechnology firm Stipple Bio, the companies said on Monday.


(Reporting by Siddhi Mahatole in Bengaluru; Editing by Sahal Muhammed)

((siddhi.mahatole@thomsonreuters.com;))

Recent news on Eli Lilly and

See all news